Treatment Outcomes of Multiple Myeloma in Developing Countries: A Systematic Review and Meta-Analysis [0.03%]
发展中国家多发性骨髓瘤的治疗结果：系统评价和 meta 分析
Jehad Almasri,Bashar Hasan,Zin Tarakji et al.
Jehad Almasri et al.
Multiple myeloma (MM) treatment outcomes in developing countries may be impacted by resource constraints. This systematic review and meta-analysis evaluated efficacy outcomes of MM treatments across developing regions. Comprehensive searche...
DAIR to Be Different: Successful Use of DAIR Regimen, a Novel Treatment Combination for EBV-induced HLH [0.03%]
不一样的DAIR：EB病毒所致噬血细胞综合征使用DAIR方案新型治疗组合的病例报告
Adam Bouhadana,Amir Steinberg
Adam Bouhadana
Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening hyperinflammatory syndrome caused by uncontrolled immune activation and hemophagocytosis. In adults, Epstein-Barr virus (EBV) infection is a known trigger. This report describes...
Networking for a successful career in clinical hematology: a strategic approach [0.03%]
临床血液学成功职业的战略式发展：打造良好的人际关系
Mohamad Mohty,Rahul Banerjee
Mohamad Mohty
Networking is fundamental to career development in clinical hematology, providing avenues for knowledge exchange, collaborations, and professional growth. This manuscript examines specific strategies for networking within this specialized f...
Improving Advanced-Line Multiple Myeloma Care: Insights and Real-World Challenges from the EMMY Study [0.03%]
来自EMMY研究的关于改善多发性骨髓瘤晚期患者护理的见解及现实世界的挑战
Titouan Cazaubiel,Olivier Decaux,Bruno Royer et al.
Titouan Cazaubiel et al.
Managing multiple myeloma (MM) patients receiving advanced (four or more) lines of treatment is a complex challenge. Therefore, real-world data are essential to better understand and address the medical need of this challenging population. ...
Consensus Guidelines and Recommendations for the anti-CD38-based Therapy in Clinical Practice for Relapsed/Refractory Multiple Myeloma: From the Pan-Pacific Multiple Myeloma Working Group [0.03%]
复发难治多发性骨髓瘤抗CD38抗体类药物临床应用中国专家共识及推荐意见：泛太平洋多发性骨髓瘤工作组发起
Wenming Chen,Zhen Cai,Chor Sang Chim et al.
Wenming Chen et al.
Anti-CD38 monoclonal antibodies (mAbs), including daratumumab and isatuximab, have become key components of treatment for relapsed/refractory multiple myeloma (RRMM). This expert consensus provides evidence-based guidance on their optimal u...
Viviana Cortiana,Harshitha Vallabhaneni,Jenna Ghazal et al.
Viviana Cortiana et al.
Myelodysplastic syndromes (MDS) represent a heterogeneous group of clonal hematopoietic diseases sharing ineffective hematopoiesis, cytopenias, and a high risk of evolution to acute myeloid leukemia (AML). The current MDS classification sys...
Large intramuscular hematoma due to acquired Factor VIII inhibitors in post Polycythemia Vera-Myelofibrosis [0.03%]
因获得性八因子抑制物导致的大腿肌肉内血肿（曾患多毛细胞白血病-骨髓纤维化）
Raghuveer S Prabhu,Sarath R V S,Rahmathullah S N
Raghuveer S Prabhu
A 59-year-old man with Janus kinase-2 (JAK2) V617F mutation-positive polycythemia vera, evolving to myelofibrosis presented with a right thigh hematoma. Further evaluation showed prolonged activated partial thromboplastin time (aPTT), which...
The short-term Cardiotoxicity after Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective single center experience [0.03%]
同种异基因造血干细胞移植后的心脏毒性：单中心回顾性分析体验
Jean El Cheikh,Ibrahim Hasan,Mustafa Saleh et al.
Jean El Cheikh et al.
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is considered the best cure for many hematologic diseases, but it is associated with multiple short and long term cardiovascular adverse effects. This retrospective study assess...
Moving the Needle in KMT2A Rearranged Pediatric B-Cell Acute Lymphoblastic Leukemia: Newer agents and novel approaches [0.03%]
儿童B细胞急性淋巴细胞白血病KMT2A重排的治疗进展：新药和创新疗法
Anwesha Ray,Aditi Jain,Mona Vijayaran et al.
Anwesha Ray et al.
Pediatric B-cell acute lymphoblastic leukemia (B-ALL) has been the poster child of progressive success in the development of leukemia therapy. Among the genomically defined high-risk subtypes of B-ALL are those with KMT2A-rearrangement (r) ...
Clinical Characteristics and Treatment Outcomes of Acute Myeloid Leukemia in Adolescent and Young Adult versus Adult Patients: A Single-Center Experience in Qatar [0.03%]
卡塔尔单中心年轻成人急性髓系白血病患者与成人患者的临床特征及治疗结局的比较研究
Shehab Fareed,Abdulrahman Fadhl Al-Mashdali,Hawraa Shwaylia et al.
Shehab Fareed et al.
Acute myeloid leukemia (AML) presents differently across age groups, with unique challenges in the adolescent and young adult (AYA) populations. This study compares clinical characteristics and outcomes between AYA and adult AML patients in...